Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001377310 | SCV001574612 | pathogenic | not provided | 2024-07-22 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 312 of the MUT protein (p.Gly312Val). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with methylmalonic aciduria (PMID: 16281286, 26790480). ClinVar contains an entry for this variant (Variation ID: 218988). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MUT protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV000203346 | SCV000258501 | not provided | Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency | no assertion provided | literature only | ||
Natera, |
RCV001833169 | SCV002077388 | likely pathogenic | Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency | 2021-05-10 | no assertion criteria provided | clinical testing |